Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
AN2
AN2 is a novel medicines targeting infectious diseases founded by Eric Easom.
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Organization
Company
CEO
Eric Easom
0
Legal Name
AN2 Therapeutics, Inc.
Company Operating Status
Active
Crunchbase URL
crunchbase.com/organiz...apeutics
Email Address
info@an2therapeutics.com
Founder
Eric Easom
0
Full Address
1800 El Camino Real, Suite D Menlo Park, CA 94027, USA
Industry
Technology
Biology
Biotechnology
Biopharmaceutical
Investors
Hatteras Venture Partners
BioRock Ventures
Adjuvant Capital
Brii Biosciences
Surveyor Capital
RA Capital Management
Latest Funding Round Date
January 7, 2022
Latest Funding Round Amount (USD)
80,000,000
Latest Funding Type
Series B Round
LinkedIn URL
@company/an2-therapeutics-inc
Location
San Francisco
Menlo Park, California
Number of Employees (Ranges)
11 – 50
Phone Number
+16503319090
Pitchbook URL
pitchbook.com/profiles...343121-05
Exchange
Nasdaq
Ticker Symbol
ANTX
Total Funding Amount (USD)
92,000,000
Twitter URL
@AN2Therapeutics
Official Website
an2therapeutics.com
Find more companies like AN2
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE